Active Psoriatic Arthritis Market: Future Opportunities, Market Analysis & Outlook To 2027

 

Market Size – USD 7.15 Billion in 2019, Market Growth – CAGR of 9.2%, Market Trends– Growing Prevalence of Psoriasis

According to the current analysis of Emergen Research, the global Active Psoriatic Arthritis Market was valued at USD 7.15 billion in 2019 and is expected to reach USD 13.64 billion by 2027, at a CAGR of 9.2%. Significant growth in incidences of active psoriatic arthritis is observed across emerging countries together with increasing elderly population. Also, poor standard of living due to stressful work-life balance resulting in the overstimulation of immune system.

Rising advancements in biosimilars and robust pipeline of biologic products are expressively enhancing the availability of safe and efficient psoriatic arthritis treatment. High incidence of psoriatic arthritis is extensively experienced by those patients who are already suffering from plague psoriasis. These scenarios are actively contribute to the industry growth of active psoriatic arthritis treatment and therefore, demand for drugs linked with this treatment are also likely to escalate in the forecast period.

To get holistic FREE SAMPLE of the report, please click: https://www.emergenresearch.com/request-sample-form/72

North America is dominating the revenue share of the industry owing to availability of technologically advanced products, efficient treatments, favourable reimbursement scenarios, increase in purchasing power of the people and high occurrence rate of active psoriatic arthritis among elderly population. However, high cost linked with the treatment, unawareness among people and strict government policies among other shortcomings are likely to restrain the industry growth.

The leading manufactures in the market include Novartis International AG, Johnson & Johnson Services, AbbVie, AstraZeneca, Amgen, Celgene Corporation, Bristol-Myers Squibb Company, Bausch Health Companies, Eli Lilly and Company and Pfizer among other companies

Browse complete report description and visit our website @ https://www.emergenresearch.com/industry-report/active-psoriatic-arthritis-market

Regional Scope: North America; Europe; Asia Pacific; Central & South America; MEA

Product Outlook (Revenue in Million USD; 2017–2027)

1. Prescriptions
2. OTC
3. Other

Drug Class Outlook (Revenue in Million USD; 2017–2027)

1. Biologics
2. Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
3. Non-Biologic Disease Modifying Anti-Rheumatic Drugs (DMARDs)
4. Other

By Route of Administration (Revenue in Million USD; 2017–2027)

1. Injectable
2. Oral
3. Topical

North America accounted for the largest market share of approximately, 37.2% in the global Active Psoriatic Arthritis market in 2019 primarily due to growing incidences of chronic asthma and rhinosinusitis symptoms along with competent infrastructure and favorable reimbursement scenarios. Owing to such promising market drivers, the North American market is anticipated to grow significantly through the forecast period.

Interested in this report? Get your FREE sample now! https://www.emergenresearch.com/request-sample-form/72

Table of Content

Chapter 1. Methodology & Sources

    1.1. Market Definition

    1.2. Research Scope

    1.3. Methodology

    1.4. Research Sources

          1.4.1. Primary

          1.4.2. Secondary

          1.4.3. Paid Sources

    1.5. Market Estimation Technique

Chapter 2. Executive Summary

    2.1. Summary Snapshot, 2019-2027

Chapter 3. Key Insights

Chapter 4. Active Psoriatic Arthritis Market Segmentation & Impact Analysis

    4.1. Active Psoriatic Arthritis Market Material Segmentation Analysis

    4.2. Industrial Outlook

          4.2.1. Market indicators analysis

          4.2.2. Market drivers analysis

                    4.2.2.1. Intensifying Prevalence of psoriatic arthritis

                    4.2.2.2. Emergence of potential medication

                    4.2.2.3. Healthcare reimbursements scenario

                    4.2.2.4. Availability of research finds from public and private bodies

          4.2.3. Market restraints analysis

                    4.2.3.1. High cost of treatment

                    4.2.3.2. Side effects associated with the treatment/surgery

    4.3. Technological Insights

    4.4. Clinical Pipeline Analysis

    4.5. Regulatory Framework

    4.6. Porter’s Five Forces Analysis

    4.7. Competitive Metric Space Analysis

    4.8. Price trend Analysis

    4.9. Covid-19 Impact Analysis

Chapter 5. Active Psoriatic Arthritis Market By Product Type Insights & Trends, Revenue (USD Million)

    5.1. Product Type Dynamics & Market Share, 2019 & 2027

          5.1.1. Prescriptions Products

          5.1.2. Over-the-Counter (OTC)

          5.1.3. Other

Chapter 6. Active Psoriatic Arthritis Market By Drug Class Insights & Trends Revenue (USD Million)

    6.1. Drug Class Dynamics & Market Share, 2019 & 2027

          6.1.1. Biologics

          6.1.2. Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)

          6.1.3. Non-Biologic Disease Modifying Anti-Rheumatic Drugs (DMARDs)

          6.1.4. Other

Continue…

Thank you for reading our report. For further information or queries about the report or customization options, please get in touch with us. We will ensure your report is tailored according to your requirements.